Diana C. Grootendorst - Publications

Observational studies are complementary to randomized controlled trials.

Journal: Nephron. Clinical practice

Published: December 04, 2009

Screening: why, when, and how.

Journal: Kidney international

Published: June 19, 2009

Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: July 12, 2007

Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD.

Journal: Thorax

Published: June 19, 2007

Mechanisms of bronchial hyperreactivity in asthma and chronic obstructive pulmonary disease.

Journal: Proceedings of the American Thoracic Society

Published: August 23, 2005

Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD).

Journal: Pulmonary pharmacology & therapeutics

Published: October 29, 2003

Does a single dose of the phosphodiesterase 4 inhibitor, cilomilast (15 mg), induce bronchodilation in patients with chronic obstructive pulmonary disease?

Journal: Pulmonary pharmacology & therapeutics

Published: April 03, 2003

Selective phosphodiesterase inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.

Journal: Current opinion in allergy and clinical immunology

Published: April 20, 2002